Surface Oncology, Inc. Quarterly Debt-to-equity in % from Q3 2018 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Surface Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q3 2018 to Q2 2023.
  • Surface Oncology, Inc. Debt-to-equity for the quarter ending June 30, 2023 was 64.4 %, a 25.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 64.4 +13.1 +25.5% Jun 30, 2023
Q1 2023 64.9 +17.7 +37.5% Mar 31, 2023
Q4 2022 57.3 +13.8 +31.6% Dec 31, 2022
Q3 2022 55.5 +16.4 +42% Sep 30, 2022
Q2 2022 51.3 +8.86 +20.9% Jun 30, 2022
Q1 2022 47.2 +0.58 +1.24% Mar 31, 2022
Q4 2021 43.5 -10.3 -19.1% Dec 31, 2021
Q3 2021 39 -35.5 -47.7% Sep 30, 2021
Q2 2021 42.5 -40 -48.5% Jun 30, 2021
Q1 2021 46.7 -44.3 -48.7% Mar 31, 2021
Q4 2020 53.8 -38.3 -41.6% Dec 31, 2020
Q3 2020 74.6 -4.49 -5.68% Sep 30, 2020
Q2 2020 82.5 +8.26 +11.1% Jun 30, 2020
Q1 2020 91 +21 +30% Mar 31, 2020
Q4 2019 92.1 -9.94 -9.74% Dec 31, 2019
Q3 2019 79.1 -168 -68% Sep 30, 2019
Q2 2019 74.2 Jun 30, 2019
Q1 2019 70 Mar 31, 2019
Q4 2018 102 Dec 31, 2018
Q3 2018 247 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.